Amgen's Osteoporosis Drug Denosumab (Prolia) at FDA Panel - Health Blog - WSJ
Links shared publicly online about this topic.
- 1,824total visits
Amgen's Osteoporosis Drug Denosumab (Prolia) at FDA Panel - Health Blog - WSJ
But several analysts said Amgen's experimental bone drug denosumab fared well enough to stay on track.
View full resource at blogs.wsj.com
Tags: Bone, Osteoporosis, Osteoporosis Medication, Drug, FDA, Prolia, Amgen
Most Recently Shared on August 14, 2009 at 1:42 pm By:
Analysts react to FDA panel: http://tinyurl.com/p8dmla Amgen's future in Denosumab
UPDATE 2-European experts recommend Amgen, Glaxo bone drug | Reuters
reuters.com — “* Prolia recommended for osteoporosis in women and men* EU green light follows delay at U.S. FDA * Amgen and Glaxo to share commercialisation in Europe (Adds further details on drug and initial” View full resource at reuters.com
Most Recently Shared on December 18, 2009 at 1:07 pm By:
European panel recommends Amgen, Glaxo bone drug denosumab. http://is.gd/5sp4m
Advertisement
